CryoConcepts Funding: How Much Did They Raise & Key Investors

How Much Did CryoConcepts Raise?
Funding & Key Investors

CryoConcepts has solidified its position as a dominant force in the medical device sector, securing a total capital infusion of $784K. This trajectory of financial growth is underscored by a recent strategic investment of $434K, which serves to bolster the company's operational capacity and global market reach. By leveraging these debt-based financing instruments, the firm continues to scale its infrastructure to meet the rising demand for specialized cryotherapy solutions across diverse international markets.

The company's ability to attract significant backing reflects its long-standing reputation for technical excellence and its robust portfolio of FDA-cleared products. As the organization transitions into its next phase of enterprise-level expansion, this influx of liquidity provides the necessary runway to accelerate product development and deepen its penetration into the aesthetic and veterinary segments.

What is CryoConcepts?

CryoConcepts

Manufacturing

Medical Devices & Equipment

Established in 1991, CryoConcepts has emerged as a premier innovator in the field of cryosurgery and cryotherapy. The company maintains a comprehensive product ecosystem that spans Over-the-Counter (OTC) healthcare, professional medical applications, aesthetic treatments, and veterinary care. Central to its market success is the Histofreezer brand, which has become a standard for at-home and clinical cryo-based skin treatments. With a footprint extending across 40 countries, CryoConcepts distinguishes itself through rigorous quality standards and strategic partnerships with global consumer product entities. Their commitment to advancing cryo-based technology ensures they remain at the forefront of non-invasive dermatological and therapeutic solutions.

How much funding has CryoConcepts raised?

CryoConcepts has raised a total of $784K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$434K

Debt (2020): $350K with participation from PPP

Debt (2021): $434K led by PPP

Key Investors in CryoConcepts

PPP

Public-Private Partnership

What's next for CryoConcepts?

With the recent capital injection, CryoConcepts is well-positioned to optimize its supply chain and enhance its R&D initiatives for next-generation cryo devices. The strategic focus will likely shift toward expanding the reach of its OTC product lines while simultaneously exploring new applications for its proprietary technology in emerging medical markets. By maintaining a disciplined approach to debt management and reinvestment, the company aims to fortify its competitive moat against new entrants in the aesthetic and veterinary sectors. Future growth will be driven by continued innovation in patient-centric cryotherapy, ensuring that CryoConcepts remains a trusted partner for healthcare providers and consumers alike on a global scale.

See full CryoConcepts company page

See More Financial Insights